Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Advanced Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IV Prostate Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (Office of Clinical Research) · OCRReferral@health.ucdavis.edu · 916-382-6970
Contact: Principal Investigator (Mamta Parikh)

Study leads

Mamta Parikh
Principal Investigator
University of California, Davis

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Prostate Cancer · Prostate Cancer (Adenocarcinoma) · Prostate Cancer Metastatic Disease

Abroad (travel likely)RecruitingPHASE2

Boston, United States

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Cancer Survivor · Obesity · Overweight

Abroad (travel likely)Recruiting

Buffalo, United States

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

Prospective Prostate Cancer and Patient-reported Outcomes Registry

Prostate Cancer · Adenocarcinoma of the Prostate · Locally Advanced Prostate Carcinoma

Abroad (travel likely)Recruiting

Dendermonde, Belgium · Leuven, Belgium